Abstract GS2-10: Nimbus: A phase 2 trial of nivolumab plus ipilimumab for patients with hypermutated her2-negative metastatic breast cancer (MBC)
暂无分享,去创建一个
E. Winer | S. Reddy | B. Overmoyer | E. Mittendorf | L. Emens | R. Barroso-Sousa | S. Tolaney | N. Tayob | Tianyu Li | V. Attaya | Paulina B. Lange | Molly K. DiLullo | Jeffrey Kimmel | M. DiLullo